Latest Options News

Barton Gold has raised $25.5 million through an institutional placement, fully funding critical feasibility studies and resource upgrades across its Challenger, Tunkillia, and Tolmer projects in South Australia.

Altair Minerals has brought on geoscience veteran Simon Bolster as Technical Advisor to refine drill targets and accelerate exploration at its Greater Oko gold project, leveraging his expertise in regolith geochemistry and rapid assay technology.

Theta Gold Mines has locked in a fully subscribed US$90 million senior secured bond to complete the TGME Gold Mine Project in South Africa, targeting first gold production in early 2027.

BluGlass has locked in a $1 million firm commitment through an option shortfall agreement, with potential to raise $1.5 million, reinforcing its financial position after an upsized $8 million placement. The funds will accelerate GaN laser contract delivery and working capital.

1414 Degrees has formed an Aerospace, Drone & Defence Advisory Board featuring six veterans from top defence and aerospace firms to accelerate the rollout of its SiNTL silicon anode battery technology targeting drones and adjacent markets.

Adavale Resources has boosted its Parkes Project gold resource by 44% to 166,000 ounces through a 100% scrip acquisition of the Calarie mining licence and three exploration licences, consolidating its belt-scale position in NSW’s Lachlan Fold Belt.

Orange Minerals NL has agreed to sell its 51% interest in the Calarie Project tenements to Adavale Resources, receiving shares and options in return. This move supports Orange Minerals' focus on its core gold projects in Ghana and Western Australia.

Canadian Phosphate (ASX: CP8) is raising up to AUD 4.85 million via a renounceable rights issue at a 22% discount, aiming to accelerate development of its newly acquired Diamond Mountain Project in Utah and advance exploration in Canada.

Evion Group has increased the size of its second tranche placement, lifting total capital raised to A$7.24 million through the issue of over 241 million shares at 3 cents each. The second tranche awaits shareholder approval at a July meeting, including director participation and free attaching options.

Sequoia Financial Group has pushed back its interim dividend payment to 29 June 2026 due to unresolved court proceedings and negotiations over the sale of its InterPrac subsidiary. The Federal Court has set a tight timetable for filings on the Share Sale Agreement status, with a potential hearing in July.

Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.

Amplia Therapeutics reported encouraging mature data from its ACCENT pancreatic cancer trial showing improved survival and response rates with narmafotinib. The company raised $27.5 million to fund development and manufacturing scale-up, while discontinuing a parallel trial due to chemotherapy toxicity.